Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Laeknabladid
|
January 13, 2010
[Results of individually adjusted radioiodine treatment of hyperthyroidism.]
G Sigthorsson, M Kjeld
Laeknabladid
|
January 13, 2010
[Measurement of thyroid autoantibodies in Graves' disease.]
G Sigthorsson, O Olafsson, M Kjeld
Best Practice & Research. Clinical Gastroenterology
|
September 22, 2001
Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine
S Smale, J Tibble, G Sigthorsson, et al.
Scandinavian Journal of Gastroenterology
|
September 20, 2000
Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat
J A Tibble, G Sigthorsson, R Foster, et al.
Inflammopharmacology
|
October 23, 2009
The effects of AZD3582 [4-(nitroxy)butyl-(2S)-2-(6-methoxy-2-naphthyl) propanoate], and naproxen on key pathogenic steps in NSAID-enteropathy in the rat
M Walley, G Sigthorsson, C Hotz-Behofsits, et al.
Alimentary Pharmacology & Therapeutics
|
December 12, 2001
Effects of NSAIDs on cryoprobe-induced gastric ulcer healing in rats
J Tibble, G Sigthorsson, C Caldwell, et al.
Gut
|
August 21, 2001
Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma
J Tibble, G Sigthorsson, R Foster, et al.
Gastroenterology
|
July 13, 2000
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
J A Tibble, G Sigthorsson, S Bridger, et al.
Gut
|
September 15, 2000
COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin
G Sigthorsson, R Crane, T Simon, et al.
Diseases of the Colon and Rectum
|
March 4, 2000
Assessment of ileal pouch inflammation by single-stool calprotectin assay
P Thomas, H Rihani, A Røseth, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Laeknabladid
|
January 13, 2010
[Results of individually adjusted radioiodine treatment of hyperthyroidism.]
G Sigthorsson, M Kjeld
Laeknabladid
|
January 13, 2010
[Measurement of thyroid autoantibodies in Graves' disease.]
G Sigthorsson, O Olafsson, M Kjeld
Best Practice & Research. Clinical Gastroenterology
|
September 22, 2001
Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine
S Smale, J Tibble, G Sigthorsson, et al.
Scandinavian Journal of Gastroenterology
|
September 20, 2000
Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat
J A Tibble, G Sigthorsson, R Foster, et al.
Inflammopharmacology
|
October 23, 2009
The effects of AZD3582 [4-(nitroxy)butyl-(2S)-2-(6-methoxy-2-naphthyl) propanoate], and naproxen on key pathogenic steps in NSAID-enteropathy in the rat
M Walley, G Sigthorsson, C Hotz-Behofsits, et al.
Alimentary Pharmacology & Therapeutics
|
December 12, 2001
Effects of NSAIDs on cryoprobe-induced gastric ulcer healing in rats
J Tibble, G Sigthorsson, C Caldwell, et al.
Gut
|
August 21, 2001
Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma
J Tibble, G Sigthorsson, R Foster, et al.
Gastroenterology
|
July 13, 2000
Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease
J A Tibble, G Sigthorsson, S Bridger, et al.
Gut
|
September 15, 2000
COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin
G Sigthorsson, R Crane, T Simon, et al.
Diseases of the Colon and Rectum
|
March 4, 2000
Assessment of ileal pouch inflammation by single-stool calprotectin assay
P Thomas, H Rihani, A Røseth, et al.
Page
of 3